Basic Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Jul 15, 2004; 10(14): 2091-2094
Published online Jul 15, 2004. doi: 10.3748/wjg.v10.i14.2091
Table 1 Cytotoxic activity of EOT and TCS in HepA-H cells (n = 4, mean ± SD)
DrugConcentration (mg/L)Inhibitory rate (%)
24 h36 h48 h
EOT0.1-3.1 ± 2.919.1 ± 2.615.7 ± 0.8
1.0-3.6 ± 8.17.9 ± 11.55.1 ± 2.6
10-25.0 ± 1.76.8 ± 0.13.8 ± 3.6
1009.6 ± 3.321.0 ± 2.216.2 ± 6.3
5007.6 ± 7.617.0 ± 3.013.4 ± 0.7
TCS0.1-19.9 ± 6.76.9 ± 5.2-3.7 ± 4.9
1.0-6.1 ± 6.44.7 ± 0.67.4 ± 2.7
10-16.1 ± 19.10.7 ± 2.4-11.4 ± 4.7
100-6.8 ± 1.011.9 ± 4.12.6 ± 2.3
500-3.4 ± 3.310.8 ± 5.25.9 ± 3.8
Table 2 Cytotoxic activity of EOT and TCS in HeLa cells (n = 4, mean ± SD)
DrugConcentration (mg/L)Inhibitory rate (%)
24 h36 h48 h
EOT0.13.4 ± 4.19.7 ± 7.09.9 ± 3.1
1.04.5 ± 3.711.1 ± 2.011.3 ± 1.9
1016.3 ± 3.220.9 ± 6.829.4 ± 4.1
10036.7 ± 4.044.2 ± 1.754.6 ± 3.0
50057.9 ± 3.471.8 ± 3.989.4 ± 1.9
TCS0.12.2 ± 1.72.9 ± 2.74.4 ± 3.1
1.02.9 ± 2.05.5 ± 1.26.0 ± 2.7
1016.4 ± 4.16.7 ± 2.413.0 ± 3.3
10026.3 ± 2.529.3 ± 3.947.9 ± 5.2
50039.6 ± 4.853.8 ± 4.070.2 ± 2.9